At Ubuntu Research Inc., our mission is to revolutionize patient care by forging partnerships with oncology biotech firms dedicated to discovering & developing innovative therapeutics. With over two decades of experience in pharmaceuticals and biotechnology, learned strategies in clinical trial planning & execution have led to the successful authorization of groundbreaking targeted therapies and most recently multiple cell therapy products. Our platform, DIMENSION-T, empowers organizations with tailored clinical development strategies, aiding in the swift and sustainable delivery of novel treatments.During my tenure at Autolus Therapeutics, our team advanced hematology therapies through the clinical pipeline, aimed at achieving global licenses. As a founder, my commitment to modernizing & expediting the drug development process is driven by the desire to provide patients worldwide with better, more effective treatments. The expertise in clinical trials and oncology research that I have honed is now channeled into cultivating strategic partnerships and bespoke solutions at Ubuntu Research Inc.